These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 8432350

  • 21. Nerve growth factor-induced sprouting of mature, uninjured sympathetic axons.
    Isaacson LG, Saffran BN, Crutcher KA.
    J Comp Neurol; 1992 Dec 15; 326(3):327-36. PubMed ID: 1469116
    [Abstract] [Full Text] [Related]

  • 22. Axotomized septal cholinergic neurons rescued by nerve growth factor or neurotrophin-4/5 fail to express the inducible transcription factor c-Jun.
    Hughes PE, Alexi T, Hefti F, Knusel B.
    Neuroscience; 1997 Jun 15; 78(4):1037-49. PubMed ID: 9174072
    [Abstract] [Full Text] [Related]

  • 23. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.
    Williams LR, Inouye G, Cummins V, Pelleymounter MA.
    J Pharmacol Exp Ther; 1996 May 15; 277(2):1140-51. PubMed ID: 8627526
    [Abstract] [Full Text] [Related]

  • 24. Nerve growth factor induces a dose-dependent and long-lasting increase of choline acetyltransferase activity in the septal area and hippocampus of uninjured rats.
    Vantini G, Fusco M, Schiavo N, Gradkowska M, Zaremba M, Leon A, Oderfeld-Nowak B.
    Acta Neurobiol Exp (Wars); 1990 May 15; 50(4-5):323-31. PubMed ID: 2130652
    [Abstract] [Full Text] [Related]

  • 25. Evidence for sprouting specificity following medial septal lesions in the rat.
    Crutcher KA, Chandler JP.
    J Comp Neurol; 1985 Jul 01; 237(1):116-26. PubMed ID: 4044889
    [Abstract] [Full Text] [Related]

  • 26. Effects of exogenous nerve growth factor upon sympathetic sprouting into the hippocampal formation.
    Conner JM, Varon S.
    Exp Neurol; 1995 Dec 01; 136(2):123-35. PubMed ID: 7498402
    [Abstract] [Full Text] [Related]

  • 27. Dose-dependent responses to nerve growth factor by adult rat cholinergic medial septum and neostriatum neurons.
    Vahlsing HL, Hagg T, Spencer M, Conner JM, Manthorpe M, Varon S.
    Brain Res; 1991 Jun 28; 552(2):320-9. PubMed ID: 1655171
    [Abstract] [Full Text] [Related]

  • 28. Long-term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway.
    Junard EO, Montero CN, Hefti F.
    Exp Neurol; 1990 Oct 28; 110(1):25-38. PubMed ID: 2170164
    [Abstract] [Full Text] [Related]

  • 29. Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment.
    Montero CN, Hefti F.
    J Neurosci; 1988 Aug 28; 8(8):2986-99. PubMed ID: 2842469
    [Abstract] [Full Text] [Related]

  • 30. Sympathetic response to intracranial NGF infusion in the absence of afferent input: axonal sprouting without neurotransmitter production.
    Isaacson LG, Schwenk KL, Billieu SC, Crutcher KA.
    Exp Neurol; 1996 Sep 28; 141(1):57-66. PubMed ID: 8797668
    [Abstract] [Full Text] [Related]

  • 31. Recovery of ChAT immunoreactivity in axotomized rat cholinergic septal neurons despite reduced NGF receptor expression.
    Naumann T, Straube A, Frotscher M.
    Eur J Neurosci; 1997 Jul 28; 9(7):1340-9. PubMed ID: 9240391
    [Abstract] [Full Text] [Related]

  • 32. Loss of AChE- and NGFr-labeling precedes neuronal death of axotomized septal-diagonal band neurons: reversal by intraventricular NGF infusion.
    Fischer W, Björklund A.
    Exp Neurol; 1991 Aug 28; 113(2):93-108. PubMed ID: 1868909
    [Abstract] [Full Text] [Related]

  • 33. In vivo evidence for a hippocampal adrenergic neuronotrophic factor specifically released on septal deafferentation.
    Björklund A, Stenevi U.
    Brain Res; 1981 Dec 21; 229(2):403-28. PubMed ID: 7306819
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons.
    Wilcox BJ, Applegate MD, Portera-Cailliau C, Koliatsos VE.
    J Comp Neurol; 1995 Sep 04; 359(4):573-85. PubMed ID: 7499548
    [Abstract] [Full Text] [Related]

  • 36. Intraventricular nerve growth factor administration prevents lesion-induced loss of septal cholinergic neurons in aging rats.
    Montero CN, Hefti F.
    Neurobiol Aging; 1989 Sep 04; 10(6):739-43. PubMed ID: 2628784
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reversibility of nerve growth factor's enhancement of choline acetyltransferase activity in cultured embryonic rat septum.
    Nonner D, Brass BJ, Barrett EF, Barrett JN.
    Exp Neurol; 1993 Aug 04; 122(2):196-208. PubMed ID: 8405259
    [Abstract] [Full Text] [Related]

  • 39. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.
    Strömberg I, Wetmore CJ, Ebendal T, Ernfors P, Persson H, Olson L.
    J Neurosci Res; 1990 Mar 04; 25(3):405-11. PubMed ID: 2325166
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.